pamidronate disodium 90mg/30ml solution for infusion vials
medac uk - pamidronate disodium - solution for infusion - 3mg/1ml
pamidronate disodium 3mg/ml mg/ml concentrate for soln for inf
neomed technology ltd - pamidronate disodium - concentrate for soln for inf - 3mg/ml mg/ml
pamidronate disodium 9mg/ml mg/ml concentrate for soln for inf
neomed technology ltd - pamidronate disodium - concentrate for soln for inf - 9mg/ml mg/ml
pamidronate mylan (pamidronate disodium injection 3mgml)
unimed sdn bhd - disodium pamidronate -
pamidronate disodium 3mg/ml sterile concentrate
hospira uk limited horizon, honey lane, hurley, maidenhead sl6 6rj, united kingdom - pamidronate disodium - concentrate for solution for infusion - pamidronate disodium 3 mg/ml - drugs for treatment of bone diseases
pamidronate disodium hospira 3mg/ml concentrate for solution for infusion
pfizer hellas s.a. 243 messoghion ave., neo psychiko 15451, athens, greece - pamidronate disodium - concentrate for solution for infusion - pamidronate disodium 3 mg/ml - drugs for treatment of bone diseases
aft-pamidronate
aft pharmaceuticals ltd - pamidronic acid 26mg equivalent to 30.9 mg pamidronic acid disodium - powder for injection - 30 mg - active: pamidronic acid 26mg equivalent to 30.9 mg pamidronic acid disodium excipient: mannitol phosphoric acid sodium hydroxide
aft-pamidronate
aft pharmaceuticals ltd - pamidronic acid 51.96mg equivalent to 61.74 mg pamidronic acid disodium; - powder for injection - 60 mg - active: pamidronic acid 51.96mg equivalent to 61.74 mg pamidronic acid disodium excipient: mannitol phosphoric acid sodium hydroxide
aft-pamidronate
aft pharmaceuticals ltd - pamidronic acid 78.05mg equivalent to 92.75 mg pamidronic acid disodium - powder for injection - 90 mg - active: pamidronic acid 78.05mg equivalent to 92.75 mg pamidronic acid disodium excipient: mannitol phosphoric acid sodium hydroxide
pamisol pamidronate disodium 90mg/10ml injection vial
pfizer australia pty ltd - pamidronate disodium, quantity: 9 mg - injection, concentrated - excipient ingredients: sodium hydroxide; water for injections; phosphoric acid; mannitol - treatment of conditions associated with increased osteoclast activity predominantly lytic bone metastases from breast cancer and advanced multiple myeloma. acute management of tumour-induced hypercalcaemia (hypercalcaemia of malignancy). treatment of symptomatic paget's disease of bone.